The compound is typically provided as a lyophilized peptide formulation to maintain structural stability during transport and storage
using it in people, or selling it while implying a therapeutic or muscle-building benefit, can trigger FDA enforcement action against the seller
Oral semaglutide for weight loss
In rats and dogs, a single dose of NN1213 reduced appetite in a dose-dependent manner with prolonged effects
This makes it a promising therapy for digestive disorders such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and leaky gut syndrome (intestinal permeability)
Common side effects include nausea, vomiting, constipation, and fatigue, typically mild and temporary as your body adjusts